Johnson & Johnson’s consumer health unit Kenvue on Wednesday filed to be listed as an independent company, bringing the healthcare conglomerate a step closer to completing the biggest shakeup in the 135-year history.
The filing, for Kenvue to list on the New York Stock Exchange under the ticker symbol “KVUE”, comes more than a year after Johnson & Johnson announced its plan to break up into two companies.
J&J’s pharmaceutical and medical equipment units, which make cancer treatments and surgical tools, had recorded nearly $80 billion in sales in 2021, far ahead of its consumer products revenues.
The consumer unit has also faced nearly 40,000 lawsuits alleging that its baby powder and other talc products contained asbestos later linked to mesothelioma and ovarian cancer in women who used it for personal hygiene.
General Electric’s spunoff healthcare unit, GE HealthCare Technologies , debuted as an independent company on Nasdaq on Wednesday.
Source: https://www.reuters.com/markets/deals/jjs-consumer-health-unit-kenvue-files-us-ipo-2023-01-04/